The invention concerns the use of stabilized oligonucleotides comprising at least an octamer motif of the type: 5'-purine-purine-CG-pyrimidine-pyrimidine-X.sub.1X.sub.2-3' wherein the pair X.sub.1-X.sub.2- is AT, AA, CT or TT, for preparing a medicine with antitumor activity.